<abstract xmlns="http://www.w3.org/1999/xhtml">

<sec><h3>Background</h3>
<p>Re-irradiation as a therapeutic option for locoregional recurrence in patients with recurrent, persistent tumour or second primary malignant neoplasm has great advantages for locally advanced unresectable tumours.</p>
</sec>
<sec><h3>Methods</h3>
<p>We intended to characterise the patient pool that underwent re-irradiation and to perform a comparative analysis between previously known data related to prognostic factors with an impact on 2 years OS of these patients, and evaluate the therapeutic impact of re-irradiation in patients with recurrent, persistent tumour or second primary malignant neoplasm in the head and neck region, treated at the Radiotherapy Department in Portuguese Institute of Oncology in Coimbra (IPOC), from the year 2016 to 2020.</p>
</sec>
<sec><h3>Results</h3>
<p>A total of 39 patients were included in this study. All patients were submitted to both primary radiotherapy and re-irradiation with a median time interval between treatment of 20 months (minimum: 8 – maximum: 190). Only the time between irradiations was associated with a decrease in the risk of mortality (HR=0.828; CI 95% 0.731–0.939; p=.03). There were no significant differences in terms of toxicity severity between irradiations.</p>
</sec>
<sec><h3>Conclusion</h3>
<p>Re-irradiation is an important therapeutic alternative in the treatment of patients with malignant tumours in the head and neck region.</p>
</sec>
</abstract>

Background
Re-irradiation as a therapeutic option for locoregional recurrence in patients with recurrent, persistent tumour or second primary malignant neoplasm has great advantages for locally advanced unresectable tumours.

Methods
We intended to characterise the patient pool that underwent re-irradiation and to perform a comparative analysis between previously known data related to prognostic factors with an impact on 2 years OS of these patients, and evaluate the therapeutic impact of re-irradiation in patients with recurrent, persistent tumour or second primary malignant neoplasm in the head and neck region, treated at the Radiotherapy Department in Portuguese Institute of Oncology in Coimbra (IPOC), from the year 2016 to 2020.

Results
A total of 39 patients were included in this study. All patients were submitted to both primary radiotherapy and re-irradiation with a median time interval between treatment of 20 months (minimum: 8 – maximum: 190). Only the time between irradiations was associated with a decrease in the risk of mortality (HR=0.828; CI 95% 0.731–0.939; p=.03). There were no significant differences in terms of toxicity severity between irradiations.

Conclusion
Re-irradiation is an important therapeutic alternative in the treatment of patients with malignant tumours in the head and neck region.

Re-Irradiation in Squamous Cell Carcinoma of the Head and Neck

Portuguese Institute of Oncology of Coimbra, Radiotherapy Department

Forum of Clinical Oncology

This work is licensed under the Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License.

{"article-title":"Re-Irradiation in Squamous Cell Carcinoma of the Head and Neck"}

Background
Re-irradiation as a therapeutic option for locoregional recurrence in patients with recurrent, persistent tumour or second primary malignant...

Re-Irradiation in Squamous Cell Carcinoma of the Head and Neck

Article Category: Research Article

Pubblicato online: 11 ott 2023

Pagine: 40 - 48

Ricevuto: 17 dic 2022

Accettato: 01 mar 2023

DOI: https://doi.org/10.2478/fco-2023-0002

Parole chiave
Radiotherapy, Head and Neck, Re-irradiation

© 2023 João Barros et al., published by Sciendo

This work is licensed under the Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License.

Re-Irradiation in Squamous Cell Carcinoma of the Head and Neck

Article Category: Research Article

Pubblicato online: 11 ott 2023

Pagine: 40 - 48

Ricevuto: 17 dic 2022

Accettato: 01 mar 2023

DOI: https://doi.org/10.2478/fco-2023-0002

Parole chiaveRadiotherapy, Head and Neck, Re-irradiation

© 2023 João Barros et al., published by Sciendo

This work is licensed under the Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License.

Parole chiave
Radiotherapy, Head and Neck, Re-irradiation